518 related articles for article (PubMed ID: 24055717)
1. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
[TBL] [Abstract][Full Text] [Related]
2. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
Bamaga OA; Mahdy MA; Lim YA
Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
Bwijo B; Kaneko A; Takechi M; Zungu IL; Moriyama Y; Lum JK; Tsukahara T; Mita T; Takahashi N; Bergqvist Y; Björkman A; Kobayakawa T
Acta Trop; 2003 Mar; 85(3):363-73. PubMed ID: 12659974
[TBL] [Abstract][Full Text] [Related]
5. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
Gebru-Woldearegai T; Hailu A; Grobusch MP; Kun JF
Am J Trop Med Hyg; 2005 Dec; 73(6):1131-4. PubMed ID: 16354825
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
Alifrangis M; Enosse S; Khalil IF; Tarimo DS; Lemnge MM; Thompson R; Bygbjerg IC; Rønn AM
Am J Trop Med Hyg; 2003 Dec; 69(6):601-6. PubMed ID: 14740875
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
[TBL] [Abstract][Full Text] [Related]
8. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
[TBL] [Abstract][Full Text] [Related]
10. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
[TBL] [Abstract][Full Text] [Related]
11. Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria.
Kyabayinze D; Cattamanchi A; Kamya MR; Rosenthal PJ; Dorsey G
Am J Trop Med Hyg; 2003 Sep; 69(3):247-52. PubMed ID: 14628939
[TBL] [Abstract][Full Text] [Related]
12. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.
Alifrangis M; Lemnge MM; Rønn AM; Segeja MD; Magesa SM; Khalil IF; Bygbjerg IC
Am J Trop Med Hyg; 2003 Sep; 69(3):238-43. PubMed ID: 14628937
[TBL] [Abstract][Full Text] [Related]
13. Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire.
Djaman JA; Mazabraud A; Basco L
Ann Trop Med Parasitol; 2007 Mar; 101(2):103-12. PubMed ID: 17316496
[TBL] [Abstract][Full Text] [Related]
14. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
[TBL] [Abstract][Full Text] [Related]
15. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
Tessema SK; Kassa M; Kebede A; Mohammed H; Leta GT; Woyessa A; Guma GT; Petros B
PLoS One; 2015; 10(10):e0126943. PubMed ID: 26431464
[TBL] [Abstract][Full Text] [Related]
16. Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Oguike MC; Falade CO; Shu E; Enato IG; Watila I; Baba ES; Bruce J; Webster J; Hamade P; Meek S; Chandramohan D; Sutherland CJ; Warhurst D; Roper C
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):220-229. PubMed ID: 27821281
[TBL] [Abstract][Full Text] [Related]
17. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.
Aubouy A; Jafari S; Huart V; Migot-Nabias F; Mayombo J; Durand R; Bakary M; Le Bras J; Deloron P
J Antimicrob Chemother; 2003 Jul; 52(1):43-9. PubMed ID: 12805261
[TBL] [Abstract][Full Text] [Related]
18. Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia.
Al-Farsi HM; Al-Hashami ZS; Bin Dajem SM; Al-Sheikh AA; Al-Qahtani A; Beja-Pereira A; Idris MA; Babiker HA
Infect Genet Evol; 2012 Aug; 12(6):1253-9. PubMed ID: 22709478
[TBL] [Abstract][Full Text] [Related]
19. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites.
Nzila AM; Mberu EK; Sulo J; Dayo H; Winstanley PA; Sibley CH; Watkins WM
Antimicrob Agents Chemother; 2000 Apr; 44(4):991-6. PubMed ID: 10722502
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon.
Bouyou-Akotet MK; Mawili-Mboumba DP; Tchantchou Tde D; Kombila M
J Antimicrob Chemother; 2010 Mar; 65(3):438-41. PubMed ID: 20053688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
